Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/07/2003USH2085 High molecular weight polypeptides used to screen for enzyme inhibitors, such as transferases, hydrolases or proteolytic enzymes; antibiotic resistance
10/07/2003US6630619 Insecticides; insecticidal proteins; genetic engineering; nematodes; symbionic bacteria; use of isolated polynucleotide encoding insecticidal protein to transform insect-specific viruses, bacteria, yeasts and plants to control insect pests
10/07/2003US6630618 Transgenic plants having non-pathogen induced systemic acquired resistance (SAR)
10/07/2003US6630617 Enzymes involved in squalene metabolism
10/07/2003US6630616 Arabidopsis MPC1 gene and methods for controlling flowering time
10/07/2003US6630615 Plants; gene expression; promoters; neoxanthin cleavage enzyme activity; genetic engineering; use of isolated nucleotide sequences to transform plants with genes that will enhance the resistance of the plants to diseases
10/07/2003US6630614 Genetic engineering; cassettes; transgenic plants; nucleotide sequences; polynucleotides; use in modulating Rad21 to regul-ate meiotic recombination and DNA double-strand break repair to improve production and quality of crops such as corn
10/07/2003US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants
10/07/2003US6630612 Transgenic mouse embryo; for use as a model in the treatment of drug abuse
10/07/2003US6630585 Method for purifying nucleic acids from feces
10/07/2003US6630575 B7-H2 Polypeptides
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630573 Tau-conotoxin peptides
10/07/2003US6630571 Mammalian growth factor-7
10/07/2003US6630455 Methods for inducing mucosal immune responses
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630359 Micro-system with multiple points for chemical or biological analysis
10/07/2003US6630351 Transfecting a cell by attaching a reversible labile membrane activity inhibitor to a melittin peptide; adding peptide to solution containing the nucleic acid; endocytosis
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630347 Endothelial NOS transgenic animals and methods of use
10/07/2003US6630346 Gene therapy for obesity
10/07/2003US6630345 Isolated DNA soup from amino acid sequence 1 or 2
10/07/2003US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells
10/07/2003US6630343 Hepatitis C virus culture system
10/07/2003US6630341 Phosphohexuloisomerase and gene therefor
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors
10/07/2003US6630330 Ascorbic acid production from yeast
10/07/2003US6630329 Generating a library of mutant nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplification reaction mixture and inosine, amplify, recover mutant nucleotide sequences
10/07/2003US6630328 Increasing production of proteins in gram-positive microorganisms
10/07/2003US6630327 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630325 Compositions, methods and kits relating to remodel
10/07/2003US6630324 Aldehyde reductase bidirectional promoter and its use
10/07/2003US6630322 Adenovirus comprising DNA with a origin of replication of epstein-barr virus, promoter, nucleotide sequence encoding a protein and internal ribosome entry site sequence of an encephalomyocarditis virus; site-specific recombination
10/07/2003US6630321 Switching off expression via a promoter; contacting cells with the candidate drug; useful in high throughput screening for antimicrobial agents
10/07/2003US6630319 Containing a proof-reading function; chimeric enzyme; Pyrococcus and Thermus; useful in primer extension techniques, nucleic acid sequencing and amplification
10/07/2003US6630317 Methods for obtaining, identifying and applying nucleic acid sequences and (poly)peptides which increase the expression yields of periplasmic proteins in functional form
10/07/2003US6630315 Adsorbing bacterial toxins by contacting with a material having an immobilizing carrier; use in detecting exotoxins in blood and urine and in treatment of sepsis and autoimmune diseases
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630306 Bioreactive allosteric polynucleotides
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630300 Nucleotide sequences for use in the detection of viral infection of foods
10/07/2003US6630299 Fluorescence detection
10/07/2003US6630298 HCV antigen/antibody combination assay
10/07/2003US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
10/07/2003US6630148 Amino acid sequence binds to naturally occurring patched receptor; generate and/or maintain an array of vertebrate tissue; expression of secondary signaling molecules, such as Transforming Growth Factors and fibroblast growth factors
10/07/2003US6630143 Monoclonal antibodes, treating hematopoietic disorders, in particular, aplastic anemia and myelodysplastic syndromes
10/07/2003US6630141 Purified DNA including a sequence encoding an Ikaros protein; Alzheimer's disease; differentiation and generation of T cells
10/07/2003US6630138 Protein C derivatives
10/07/2003CA2321781C Particle bombardment transformation of brassica
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2256457C Passive internal references for the detection of nucleic acid amplification products
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2076320C Process for producing peptide
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/07/2003CA1341442C Transgenic animals
10/02/2003WO2003081471A1 Apparatus for managing gene expression data
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081252A1 Arrays
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081210A2 Identification of kinase inhibitors
10/02/2003WO2003081202A2 Bioconjugate-nanoparticle probes
10/02/2003WO2003080869A2 Storing and detecting nucleic acid administered to a solid carrier
10/02/2003WO2003080865A1 Primers for detecting food poisoning bacteria and a use thereof
10/02/2003WO2003080864A1 Histone deacetylase: novel molecular target of neurotoxicity
10/02/2003WO2003080862A1 Method and devices for dna methylation analysis
10/02/2003WO2003080857A2 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080855A2 Deracemisation of amines
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080849A2 4-ketocarotenoids in flower petals
10/02/2003WO2003080848A1 Biobeads having foreign genetic substance immobilized to calcium alginate
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080846A1 Method of producing high-titre lentiviral vectors
10/02/2003WO2003080845A1 Use of tea leaf extract for inhibiting microbial transformant
10/02/2003WO2003080844A2 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity
10/02/2003WO2003080843A1 Method for l-threonine production
10/02/2003WO2003080842A1 Zearalenone-detoxifying enzyme gene and transformant having the gene transferred thereinto
10/02/2003WO2003080841A1 Calcineurin activators
10/02/2003WO2003080840A1 A method of inspecting the genetic susceptibility of h.pylori related gastric carcinoma and the use of it
10/02/2003WO2003080839A2 Antigen fragments for the diagnosis of toxoplasma gondii
10/02/2003WO2003080838A1 Novel meloidogyne-resistance gene and utilization thereof
10/02/2003WO2003080837A1 Production of recombinant che a 1 allergen from chenopodium album and system of isolating and purifying same
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080834A2 Purification methods for oligonucleotides and their analogs
10/02/2003WO2003080833A1 Xanthosine methylase and use thereof
10/02/2003WO2003080830A1 Modified promoter
10/02/2003WO2003080829A1 Dna trap/release apparatus using channel and method of trapping and releasing dna
10/02/2003WO2003080828A2 Nucleic acid molecules involved in the synthesis of melithiazols
10/02/2003WO2003080826A1 Saccharomyces cerevisiae yeast strain with improved phytase activity
10/02/2003WO2003080825A2 Further bmp-2 inducible kinases and the uses thereof
10/02/2003WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections